...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Characterization of picroside II metabolites in rats by ultra-high-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem mass spectrometry
【24h】

Characterization of picroside II metabolites in rats by ultra-high-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem mass spectrometry

机译:超高效液相色谱-电喷雾电离四极杆飞行时间串联质谱法表征大鼠中的苦味子苷II代谢产物

获取原文
获取原文并翻译 | 示例

摘要

Picroside II, a bioactive compound isolated from Picrorhiza scrophulariiflora Pennell, has been reported to have hepatoprotective, neuroprotective, and antioxidant effects. However, the detailed in vivo biotransformation of this compound has been rarely reported. This study aimed to investigate the metabolic profiles of picroside II in rats by using ultra-high-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry. Metabolite structures were elucidated based on accurate mass measurements of deprotonated molecules and their fragmentation patterns. Thirteen metabolites were structurally identified, and the detailed metabolic pathways were proposed. The findings revealed that after oral administration, picroside II mainly undergoes four metabolic pathways. In the first pathway, picroside II is deglycosylated to generate aglycone, which is isomerized to a dialdehyde-type intermediate. A series of metabolic reactions, including glucuronidation, subsequently occurs. In the second pathway, picroside II is subjected to ester bond hydrolysis to form vanillic acid, which is further subjected to sulfate conjugation, glycine conjugation, glucuronidation, and demethylation. In the third pathway, picroside II is directly conjugated with glucuronic acid to yield a predominant metabolite (M01) in plasma. In the fourth pathway, picroside II is directly conjugated with sulfate. These findings provide insights into the in vivo disposition of picroside II and are useful to understand the mechanism of effectiveness and toxicity of this compound as well as P. scrophulariiflora-related preparations. (C) 2016 Elsevier B.V. All rights reserved.
机译:Picroside II是一种从玄参(Picrorhiza scrophulariiflora Pennell)分离出的生物活性化合物,据报道具有保肝,神经保护和抗氧化作用。但是,这种化合物的详细体内生物转化很少见报道。本研究旨在通过使用超高效液相色谱与电喷雾电离四极杆飞行时间串联质谱联用来研究大鼠苦味甙II的代谢谱。基于去质子化分子的精确质量测量及其片段化模式,阐明了代谢物的结构。在结构上鉴定了13种代谢物,并提出了详细的代谢途径。研究结果表明,口服苦味甙II后主要经历四个代谢途径。在第一个途径中,苦味子苷II被去糖基化以生成糖苷配基,其被异构化为二醛型中间体。随后发生一系列代谢反应,包括葡萄糖醛酸化。在第二种途径中,将苦瓜苷II进行酯键水解以形成香草酸,将其进一步进行硫酸盐结合,甘氨酸结合,葡糖醛酸化和去甲基化。在第三种途径中,吡咯糖苷II直接与葡萄糖醛酸缀合,在血浆中产生主要的代谢产物(M01)。在第四个途径中,吡咯糖苷II直接与硫酸盐结合。这些发现提供了对苦味子II的体内处置的见解,并且对于理解该化合物以及玄参假单胞菌相关制剂的有效性和毒性的机理是有用的。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号